65,437 trials
Pregnancy · Overweight and Obesity
Primary: Change in Weight — 7.5; 13.4; 18.2; -5.6 kgs
Bilateral Hearing Loss · Healthy Aging
Primary: Gait Speed (Single Task) Over 1-minute Walk — 1.14; 1.02; 1.1 m/sec — p=<0.05
Pain, Chronic
Primary: Phase Angle — 58; 41 degrees
Gulf War Syndrome
Primary: Concentration of Myoinositol in the Brain — 0.001260; 0.001205 Institutional Units (IU)
Edentulous Jaw
Primary: Marginal Bone Level (MBL) Change — 0.30; 0.40 mm
HIV/AIDS · Tuberculosis
Primary: Number of Participants With and Without Non-hazardous Drinking, as Determined by Self-report and the Biomarker Phosphatidylethanol, at 3- and 6-months. — 57; 31; 266…
May-Thurner Syndrome · Deep Vein Thrombosis · Chronic Venous Insufficiency
Primary: Safety - Number of Participants Free From Major Adverse Events (MAEs) at 30 Days — 157 Participants
Lumbar Spinal Stenosis
Primary: Low Back Pain Responder Rate — 17; 3; 1; 2 Participants
to Test the Hypothesis That NHFOV is More Effective Than nCPAP in the Treatment of Respiratory Distress Syndrome (RDS) in Verypreterm Neonates
Primary: Treatment Failure Within 72 Hours After Randomization 72 Hours After Randomization Need for Invasive Mechanical Ventilation — 48; 27 Participants
Dementia
Primary: Participation Rate — 84 Participants
Pleural Diseases · Pleural Neoplasms
Primary: Malignant Pleural Infiltration Identification — 12; 27; 9; 4 Participants — p=0.023
Immunization; Infection · Pregnancy Related
Primary: Rate of Influenza Vaccination — 2382; 2496 participants
Dementia · Staff Attitude
Primary: Change in Elderspeak Measured by Diminutives Detected in Participant's Recorded Speech. — 0.03; 0.00; 0.00; 0.01 Diminutive Use per Utterance
Length of Stay · Anti Cholinergics · Surgical Procedure, Operative
Primary: Hospital Length of Stay — 6.8; 7.8; 7.5 Days
Healthy Volunteers
Primary: Pharmacokinetics (PK): Area Under the Concentration-time Curve From Hour 0 to 24 (AUC [0-24]) Hours of LOXO-305 — 55100; 51900; 59900 hour*nanograms per milliliter